A
Alan Ashworth
Researcher at University of California, San Francisco
Publications - 589
Citations - 82138
Alan Ashworth is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 134, co-authored 578 publications receiving 72089 citations. Previous affiliations of Alan Ashworth include Imperial College London & Papworth Hospital.
Papers
More filters
Journal ArticleDOI
Family History, Genetic Testing, and Clinical Risk Prediction: Pooled Analysis of CHEK2*1100delC in 1,828 Bilateral Breast Cancers and 7,030 Controls
Olivia Fletcher,Nichola Johnson,Isabel dos Santos Silva,Outi Kilpivaara,Kristiina Aittomäki,Carl Blomqvist,Heli Nevanlinna,Marijke Wasielewski,Hanne Meijers-Heijerboer,Annegien Broeks,Marjanka K. Schmidt,Laura J. van't Veer,Michael Bremer,Thilo Dörk,Elena V. Chekmariova,Anna P. Sokolenko,Evgeny N. Imyanitov,Ute Hamann,Muhammad Usman Rashid,Hiltrud Brauch,Christina Justenhoven,Alan Ashworth,Julian Peto +22 more
TL;DR: The results imply that clinical management of the daughter of a woman with bilateral breast cancer should depend on her CHEK2*1100delC carrier status, and other moderate penetrance breast cancer susceptibility alleles, together with family history data, will thus identify increasing numbers of women at potentially very high risk.
Journal ArticleDOI
Genomic profile of a secretory breast cancer with an ETV6–NTRK3 duplication
M B K Lambros,David S.P. Tan,Robin L. Jones,Radost Vatcheva,Kay Savage,Narinder Tamber,Kerry Fenwick,Alan Mackay,Alan Ashworth,Jorge S. Reis-Filho +9 more
TL;DR: This is the first time a carcinoma has been shown to harbour a duplication of the ETV6–NTRK3 translocation and the presence of an additional copy of the derivative chromosome der(15)t(12;15) coupled with deletion of the other derivative der(12)t (12; 15) in the modal population of cancer cells suggests that this was either an early phenomenon or conferred additional growth advantage on neoplastic cells.
Journal ArticleDOI
Genomic characterisation of acral melanoma cell lines.
Simon J. Furney,Samra Turajlic,Kerry Fenwick,Maryou B K Lambros,Alan Mackay,Gerda Ricken,Costas Mitsopoulos,Iwanka Kozarewa,Jarle Hakas,Marketa Zvelebil,Christopher J. Lord,Alan Ashworth,Jorge S. Reis-Filho,Meenhard Herlyn,Hiroshi Murata,Richard Marais +15 more
TL;DR: These findings provide strong circumstantial evidence to suggest that acral melanoma cell lines and acral tumours share genetic features in common and that these cells are therefore valuable tools to investigate the biology of this aggressive melanoma subtype.
Journal ArticleDOI
The ZFY gene family in humans and mice.
TL;DR: Now that there is overwhelming evidence that ZFY and TDF are distinct loci, the authors are left with a large body of data, and a question: what do these genes really do?
Journal ArticleDOI
The genomic landscape of oesophagogastric junctional adenocarcinoma
Irene Chong,Irene Chong,David Cunningham,Louise J. Barber,James Campbell,Lina Chen,Iwanka Kozarewa,Kerry Fenwick,Ioannis Assiotis,Sebastian Guettler,Isaac Garcia-Murillas,Saima Awan,Maryou B. Lambros,Naureen Starling,Andrew Wotherspoon,Gordon Stamp,David Gonzalez-de-Castro,M. Benson,Ian Chau,Sanna Hulkki,Mahrokh Nohadani,Zakaria Eltahir,Alina Lemnrau,Nick Orr,Sheela Rao,Christopher J. Lord,Alan Ashworth +26 more
TL;DR: This study provides an insight into the mutational landscape of OGJ adenocarcinomas and confirms that this is a highly mutated and heterogeneous disease, and uncovered somatic mutations in therapeutically relevant genes which may represent candidate drug targets.